The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Structure of Apolipoprotein A-I in High Density Lipoproteins
Open accessAbstract
Not long ago, high density lipoproteins (HDL) 2The abbreviations used are: HDL, high density lipoprotein; LDL, low density lipoprotein; CAD, coronary artery disease; RCT, reverse cholesterol transport; apo, apolipoprotein; ABCA1, ATP-binding cassette A1; FRET, fluorescence resonance energy transfer. were second class citizens with regard to therapeutic strategies for lowering the risk of atherosclerosis and coronary artery disease (CAD). To date, most successful approaches have focused on the better understood pathways of cholesterol synthesis and low density lipoprotein (LDL) production, the “forward” cholesterol transport pathway. For example, the statin class of cholesterol synthesis inhibitors significantly reduces LDL levels resulting in a less atherogenic plasma lipoprotein profile. However, the relatively modest improvements in mortality conferred by these drugs suggest that other factors also play significant roles in defining CAD risk. The recent discoveries of HDL-interacting cell surface proteins such as scavenger receptor BI (SR-BI) and ATP-binding cassette transporters A1 (ABCA1) and G1 (for recent reviews see Refs. 1Lee J.Y. Parks J.S. Curr. Opin. Lipidol. 2005; 16: 19-25Crossref PubMed Scopus (165) Google Scholar and 2Zannis V.I. Chroni A. Krieger M. J. Mol. Med. 2006; 84: 276-294Crossref PubMed Scopus (310) Google Scholar) have helped define the steps of reverse cholesterol transport (RCT), i.e. the movement of cholesterol from the periphery to the liver for catabolism (3Glomset J.A. J. Lipid Res. 1968; 9: 155-167Abstract Full Text PDF PubMed Google Scholar, 4Groen A.K. Oude Elferink R.P. Verkade H.J. Kuipers F. Ann. Med. 2004; 36: 135-145Crossref PubMed Scopus (55) Google Scholar). Additionally, there is growing evidence that HDL anti-inflammatory properties may contribute significant protective effects (5Barter P.J. Nicholls S. Rye K.A. Anantharamaiah G.M. Navab M. Fogelman A.M. Circ. Res. 2004; 95: 764-772Crossref PubMed Scopus (1067) Google Scholar), apparently via specific cell signaling pathways (6Seetharam D. Mineo C. Gormley A.K. Gibson L.L. Vongpatanasin W. Chambliss K.L. Hahner L.D. Cummings M.L. Kitchens R.L. Marcel Y.L. Rader D.J. Shaul P.W. Circ. Res. 2006; 98: 63-72Crossref PubMed Scopus (247) Google Scholar). These discoveries have fueled a new interest in HDL as a target for CAD treatment (7Duffy D. Rader D.J. Circulation. 2006; 113: 1140-1150Crossref PubMed Scopus (98) Google Scholar). Unfortunately, a complete understanding of HDL function has been hampered by a lack of information on its structure and the molecular basis of its interactions with other proteins. This review summarizes the latest efforts in understanding the structure of the defining protein component of HDL, apoA-I, in the various stages of the RCT pathway. ApoA-I comprises roughly 70% of the HDL protein mass and apoA-II another 15–20%. The remainder is made up of amphipathic proteins including the apoCs, apoE, apoD, apoM, apoA-IV, paroxonase and many other proteins as identified in a recent proteomics study (8Vaisar T. Pennathur S. Green P.S. Gharib S.A. Hoofnagle A.N. Cheung M.C. Byun J. Vuletic S. Kassim S. Singh P. Chea H. Knopp R.H. Brunzell J. Geary R. Chait A. Zhao X.Q. Elkon K. Marcovina S. Ridker P. Oram J.F. Heinecke J.W. J. Clin. Investig. 2007; 117: 746-756Crossref PubMed Scopus (795) Google Scholar). These lower abundance proteins are not present on all HDL particles and may actually be sequestered on compositionally distinct particles within the density class. These amphipathic proteins form stable micellar complexes with phospholipids, cholesterol, triglycerides, and cholesteryl esters. In humans, HDL exists predominantly as two major density species, HDL2 (d = 1.063–1.125 g/ml) and HDL3 (d = 1.125–1.210 g/ml) with diameters ranging from 70–120 Å. Minor, but clearly important, subspecies include lipid-poor apoA-I and nascent discoidal particles. In addition to density, HDL can be separated by major apolipoprotein species using immunoaffinity chromatography into apoA-I-containing particles that lack apoA-II (LpA-I) and those that contain both apoA-I and apoA-II (LpA-I/A-II) (9Cheung M.C. Albers J.J. J. Biol. Chem. 1984; 259: 12201-12209Abstract Full Text PDF PubMed Google Scholar). Several functional distinctions have been proposed for these species, with apoA-II thought by some to be proatherogenic. However, there are also many examples of antiatherogenic properties of apoA-II (see Ref. 10Tailleux A. Duriez P. Fruchart J.C. Clavey V. Atherosclerosis. 2003; 164: 1-13Abstract Full Text Full Text PDF Scopus (112) Google Scholar for a review). As it comprises the majority of the protein mass, structural studies of human plasma HDL must first focus on apoA-I. ApoA-I is a 243-amino acid, 28-kDa single polypeptide that lacks glycosylation or disulfide linkages. Aside from the N-terminal 44 amino acids, the apoA-I sequence appears to be organized into eight α-helical segments of 22 amino acids and tw
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942
Three-Dimensional Structure of the LDL Receptor-Binding Domain of Human Apolipoprotein E
Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., & Agard, D. A. (1991) · Science · doi:10.1126/science.2063194 · Cited by 678
Structural Analysis of Lipoprotein E Particles
Schneeweis, L. A., Koppaka, V., Lund-Katz, S., Phillips, M. C., & Axelsen, P. H. (2005) · Biochemistry · doi:10.1021/bi050872j · Cited by 39
Cited by
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
Camont, L., Chapman, M. J., & Kontush, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.013 · Cited by 471
Davidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415
Self-citationMembrane Curvature Induction and Tubulation Are Common Features of Synucleins and Apolipoproteins
Varkey, J., Isas, J. M., Mizuno, N., Jensen, M. B., Bhatia, V. K., Jao, C. C., Petrlova, J., Voss, J. C., Stamou, D. G., Steven, A. C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139576 · Cited by 319
High Density Lipoprotein Structure–Function and Role in Reverse Cholesterol Transport
Lund-Katz, S., & Phillips, M. C. (2010) · Subcellular Biochemistry · doi:10.1007/978-90-481-8622-8_7 · Cited by 262
Lecithin: cholesterol acyltransferase – from biochemistry to role in cardiovascular disease
Rousset, X., Vaisman, B., Amar, M., Sethi, A. A., & Remaley, A. T. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328329233b · Cited by 177
Metadata
- Authors
- Davidson, W. S., & Thompson, T. B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 282
- Issue
- 31
- Pages
- 22249-22253
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1971057241
- Cited by
- 213
- References
- 4
- FWCI
- 21.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Structure of Apolipoprotein A-I in High Density Lipoproteins. https://app.cochat.ai/papers/10.1074/jbc.r700014200
- The paper
- Davidson, W. S., & Thompson, T. B. (2007). The Structure of Apolipoprotein A-I in High Density Lipoproteins. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.r700014200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.